SCHEMBL1445133

SCHEMBL1445133

COc1ccncc1-c1ccncn1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNT1 O60563 1/20 0.60
▸ CCNA2 P20248 1/20 0.60
▸ CDK2 P24941 1/20 0.60
▸ CDK9 P50750 1/20 0.60
▸ CCNA1 P78396 1/20 0.60
▸ CDK5 Q00535 1/20 0.60
▸ CDK5R1 Q15078 1/20 0.60
▸ CYP1A2 P05177 8/20 0.43
▸ CYP2D6 P10635 6/20 0.43
▸ CYP2C19 P33261 6/20 0.43
▸ CYP2E1 P05181 2/20 0.43
▸ CYP2A6 P11509 2/20 0.43
▸ CYP2B6 P20813 2/20 0.43
▸ CYP2C8 P10632 1/20 0.43
▸ CYP3A4 P08684 5/20 0.43
▸ HSD17B10 Q99714 5/20 0.43
▸ TDP1 Q9NUW8 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ SCN9A Q15858 2/20 0.42
▸ CA12 O43570 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8154563 0.82 CCNT1 (0.52) CCNT1CCNA2CDK2CDK9CCNA1
SCHEMBL30141974 0.82 CCNT1 (0.52) CCNT1CCNA2CDK2CDK9CCNA1
SCHEMBL30831604 0.82 CCNT1 (0.52) CCNT1CCNA2CDK2CDK9CCNA1
SCHEMBL13537102 0.81 SMN1; SMN2 (0.49) CYP1A2CYP2D6CYP2C19CYP2E1CYP2A6
Ammonia Solution, Strong SCHEMBL1121071 0.81 CCNT1 (0.51) CCNT1CCNA2CDK2CDK9CCNA1
SCHEMBL28135263 0.79 CYP1A2 (0.51) CCNT1CCNA2CDK2CDK9CCNA1
SCHEMBL1445782 0.79 CYP1A2 (0.43) CCNT1CCNA2CDK2CDK9CCNA1
SCHEMBL2997834 0.76 CCNT1 (1.00) CCNT1CCNA2CDK2CDK9CCNA1
SCHEMBL29941740 0.76 CCNT1 (1.00) CCNT1CCNA2CDK2CDK9CCNA1
SCHEMBL27534760 0.75 CCNT1 (0.49) CCNT1CCNA2CDK2CDK9CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2480235-A2 NOVEL IODO PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF)-IMPLICATED DISEASES AND CONDITIONS University Of Louisville Research Foundation, Inc. (US) 2012-08-01 — — EP claimed
WO-2011038234-A2 NOVEL IODO PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF)-IMPLICATED DISEASES AND CONDITIONS UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) 2011-03-31 — — WO claimed
Send feedback